SCS
MDCO

Syquant Capital SAS’s Medicines Co MDCO Stock Holding History

Syquant Capital SAS’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-505,030
Closed -$42.9M – 26
2019
Q4 		$42.9M Buy
+505,030
New +$33.7M 22.09% 2

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Syquant Capital SAS's MDCO Position: Q1 2020 in Review

Syquant Capital SAS sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 505,030 shares — an estimated $42.9M sold.

Syquant Capital SAS first reported a position in MDCO in Q4 2019 and held it in 1 quarter. The position peaked at $42.9M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Syquant Capital SAS reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Syquant Capital SAS sold 505,030 Medicines Co shares in Q1 2020, an estimated $42.9M.
  • Syquant Capital SAS first reported a position in Medicines Co in Q4 2019 and held it in 1 quarter.
  • Syquant Capital SAS's Medicines Co position peaked at $42.9M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Syquant Capital SAS's 13F filing for Q1 2020, filed 14 Apr 2020.